Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.

BACKGROUND The association of butyrylcholinesterase (BuChE) with Alzheimer disease and the association of this disease with cardiovascular risk factors raise interest in the association of BuChE activity with cardiovascular risk factors and mortality. METHODS A baseline cross-sectional study was conducted between 1985 and 1987, encompassing residents > or =50 years of age living in a Jewish neighborhood in western Jerusalem. Interviews were followed by examinations and nonfasting blood sampling (available for 1807 participants). Follow-up data to April 1996 on mortality and causes of death were obtained through record linkage with the Israeli Population Registry. RESULTS BuChE activity was inversely related to age and was positively associated with serum concentrations of albumin (r = 0.35; P <0.001), cholesterol (r = 0.31; P <0.001), and triglycerides (r = 0.30; P <0.001). Enzyme activity was associated with measures of overweight, obesity, and body fat distribution (e.g., body mass index, r = 0.20; P <0.001). In multivariate analysis, the associations of enzyme activity with serum cholesterol, triglycerides, and albumin persisted strongly. After adjustment by Cox proportional hazards regression for other predictors of mortality in this population, individuals in the lowest quintile of BuChE activity had significantly higher mortality than those in the highest quintile [hazard ratios (95% confidence intervals): all-cause mortality, 1.62 (1.15-2.30); cardiovascular deaths, 1.79 (1.05-3.05)]. The association was attenuated by introduction of serum albumin into the models. CONCLUSIONS This is the first study to report on the association between BuChE and mortality. The relatively strong association of BuChE with serum lipid and albumin concentrations requires elucidation. Our results suggest that low BuChE activity may be a nonspecific risk factor for mortality in the elderly.

[1]  L. H. Easson,et al.  Choline-esterase. An enzyme present in the blood-serum of the horse. , 1932, The Biochemical journal.

[2]  J. C. Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .

[3]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[4]  G. Picheth,et al.  Butyrylcholinesterase activity and risk factors for coronary artery disease , 2002, Scandinavian journal of clinical and laboratory investigation.

[5]  A. Brock,et al.  Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter- and intra-individual variations. , 1990, Scandinavian journal of clinical and laboratory investigation.

[6]  R. Heine,et al.  Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? , 2001, Clinical science.

[7]  M. Maekawa,et al.  Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan. , 1997, Clinical chemistry.

[8]  D. Royall,et al.  Alzheimer disease as a vascular disorder: nosological evidence. , 2002, Stroke.

[9]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[10]  M. Mathews,et al.  Relationship between serum butyrylcholinesterase and the metabolic syndrome. , 2005, Clinical biochemistry.

[11]  T. Hansen,et al.  Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion , 2004, Diabetologia.

[12]  M. Luca,et al.  Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease , 2003, Neuroscience Letters.

[13]  J. Kark,et al.  Trends in blood pressure levels over time in middle-aged and elderly Jerusalem residents. , 1995, European heart journal.

[14]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[15]  R. R. Holman,et al.  Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects , 2001, Diabetologia.

[16]  M. Knedel,et al.  Eine kinetische Methode zur Bestimmung der Aktivität der Pseudocholinesterase (Acylcholin-acylhydrolase 3.1.1.8.) , 1967, Klinische Wochenschrift.

[17]  A. Dietz,et al.  Correlation of Cholinesterase with Serum Lipids and Lipoproteins , 1987, Journal of clinical pharmacology.

[18]  M. O’Malley,et al.  Standardization of Clinical Cholinesterase Measurements , 2002, International journal of toxicology.

[19]  I. Rosenberg,et al.  Nonfasting Plasma Total Homocysteine Level and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem , 1999, Annals of Internal Medicine.

[20]  R. Gofin,et al.  Risk markers for mortality among elderly men-a community study in Jerusalem. , 1982, Journal of chronic diseases.

[21]  A. Beynen,et al.  Dietary cholesterol lowers the activity of butyrylcholinesterase (EC 3.1.1.8), but elevates that of esterase-1 (EC 3.1.1.1) in plasma of rats , 1993, British Journal of Nutrition.

[22]  L. Kricka,et al.  Effects of Storage and Repeated Freezing and Thawing on Plasma Cholinesterase Activity , 1984, Annals of clinical biochemistry.

[23]  J. Kark,et al.  The prevalence of obesity and its changes over time in middle-aged and elderly men and women in Jerusalem. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[24]  J. Santerre,et al.  Mutual influence of cholesterol esterase and pseudocholinesterase on the biodegradation of dental composites. , 2004, Biomaterials.

[25]  J. L. Smith,et al.  Monographs in Human Genetics , 1972 .

[26]  Z. Janka,et al.  Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. , 2004, Life sciences.

[27]  D. R. Davies,et al.  A Relationship between Body Fat and Plasma Pseudo-Cholinesterase , 1954, British Journal of Nutrition.

[28]  P. Masson A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate. , 1989, Biochimica et biophysica acta.